Skip to main content
Demo
Company record · Zaventem
Belgian companySituation normaleAssociation sans but lucratif

Belgian IBD Research and Development

Enterprise number
0465.587.924
VAT number
BE0465587924
Registered office
Leuvensesteenweg 643, 1930 Zaventem
See the 52 companies at this address
Incorporated on
7 March 1998
Official sources·CBE·NBB: Central Balance Sheet Office·Belgian Official Gazette·Map
Members only
Health score
Show the scoreLog in

Profile

Official information from the CBE (FPS Economy).

Belgian IBD Research and Development is a Belgian company (Association sans but lucratif) whose registered office is established at 1930 Zaventem. Its main activity falls under “Activités dans le domaine de l’alimentation” (NACE 86995).

Legal form
Association sans but lucratif
Legal situation
Situation normale
Date of incorporation
7 March 1998
Main activity (NACE)
86995Activités dans le domaine de l’alimentation

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Company names

Official names in several languages: legal name, trade name, abbreviation.

Abbreviation
  • BIRD

Secondary activities

3 additional NACE codes declared.

Your risk analysis on this company

AML Company ran Belgian IBD Research and Development through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Zaventem

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Leuvensesteenweg 643
1930 Zaventem
Map
Establishment2256.984.914
Leuvensesteenweg 643
1930 Zaventem
Map

Finances & financial health

Aggregate health score computed from the Altman Z″ model, completed with qualitative factors (age, regularity of filings, public alerts).

Zone Altman
Grade
Computed on

Financial data unavailable

This company's annual accounts carry no structured JSON (filings before 2022) or have not been published yet.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about Belgian IBD Research and Development

Quick answers on Belgian IBD Research and Development's identity, contact details and official CBE information.

What is Belgian IBD Research and Development's enterprise number (CBE)?
Belgian IBD Research and Development's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 0465587924. This unique number identifies the company with every Belgian administration.
What is Belgian IBD Research and Development's VAT number?
Belgian IBD Research and Development's intra-Community VAT number is BE0465587924. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is Belgian IBD Research and Development's registered office?
Belgian IBD Research and Development's registered office is located at Leuvensesteenweg 643, 1930 Zaventem, Belgium. This address is the official one declared with the CBE.
What is Belgian IBD Research and Development's legal form?
Belgian IBD Research and Development is incorporated under the legal form “Association sans but lucratif”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was Belgian IBD Research and Development incorporated?
Belgian IBD Research and Development was entered in the Crossroads Bank for Enterprises on 7 March 1998. This date is the official start of activity declared with the CBE.
Is Belgian IBD Research and Development still active?
Yes, Belgian IBD Research and Development is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is Belgian IBD Research and Development's main activity?
Belgian IBD Research and Development's declared main activity is: Activités dans le domaine de l’alimentation (NACE code 86995). This NACE code officially classifies the company in the European nomenclature of economic activities.
How many establishments does Belgian IBD Research and Development have?
Belgian IBD Research and Development declares 1 establishment unit registered with the CBE, on top of its registered office.
Which official notices concern Belgian IBD Research and Development?
5 official notices about Belgian IBD Research and Development are available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is Belgian IBD Research and Development subject to anti-money-laundering obligations in Belgium?
On the face of it, no. Belgian IBD Research and Development's declared activity is not among the professions expressly covered by the Act of 18 September 2017. This general information is not legal advice.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
5 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2022
    1. 6 January 2022Registered office · Articles of association · Appointments · ResignationsView the notice22301174
  2. 2019
    1. 13 November 2019Registered office · Appointments · ResignationsView the notice19149065
  3. 2016
    1. 8 April 2016Registered officeView the notice16049346
    2. 23 March 2016Company name · Appointments · ResignationsView the notice16042151
  4. 2013
    1. 19 December 2013Registered office · Company name · Appointments · ResignationsView the notice13191247

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
Unlock AI insightsSee the plans

Similar companies

Same business sector and geographic area.

SALIGHEH RADIOLOGIE

0806.351.201
1930 Zaventem

AXXON,PHYSICAL THERAPY IN BELGIUM

0820.241.502
1930 Zaventem

Patient Expert Center

0732.737.109
1930 Zaventem

Institut de Pathologie et de Génétique

0408.333.871
6041 Charleroi

Association interhospitalière de la Région de Charleroi

0440.543.118
6060 Charleroi

Thuisverpleging Samson Luc

0774.582.216
1930 Zaventem

KINEZA

1017.468.731
1930 Zaventem

EGHT CARE

0753.612.893
1930 Zaventem

ROB ASSISTANCE

0780.352.132
1930 Zaventem
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

Create an account

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.